文章摘要
血清CCL3 CCL5水平与类风湿关节炎合并骨质疏松的相关性研究
Correlation between serum CCL3, CCL5 levels and osteoporosis in patients with rheumatoid arthritis
投稿时间:2025-06-27  
DOI:10.3969/j.issn.1000-0399.2026.04.004
中文关键词: 类风湿关节炎  骨质疏松  趋化因子配体3  趋化因子配体5
英文关键词: Rheumatoid arthritis  Osteoporosis  Chemokine ligand 3  Chemokine ligand 5
基金项目:安徽省高等学校科学研究项目(编号:2022AH050777),安徽省科技厅重点研究与开发计划项目(编号:2022e07020060)
作者单位E-mail
阮圣霆 230000 安徽合肥 安徽医科大学第三附属医院(合肥市第一人民医院)风湿免疫科  
汪珊 230000 安徽合肥 安徽医科大学第三附属医院(合肥市第一人民医院)风湿免疫科 shanw78@163.com 
汪毅 230000 安徽合肥 安徽医科大学第三附属医院(合肥市第一人民医院)肿瘤科  
查旭雯 230000 安徽合肥 安徽医科大学第三附属医院(合肥市第一人民医院)风湿免疫科  
姜颖 230000 安徽合肥 安徽医科大学第三附属医院(合肥市第一人民医院)风湿免疫科  
摘要点击次数: 388
全文下载次数: 111
中文摘要:
      目的 探讨趋化因子配体3(CCL3)及趋化因子配体5(CCL5)与类风湿关节炎(RA)合并骨质疏松(OP)的相关性。方法 选择2022年1月至2025年12月就诊于安徽医科大学第三附属医院(合肥市第一人民医院)的224例RA患者为研究对象,根据骨密度(BMD)分为OP组(BMD≤-2.5 SD,n=124)和非OP组(BMD>-2.5 SD,n=100)。使用酶联免疫吸附测定(ELISA)法检测血清CCL3和CCL5水平。采用单因素logistic回归初步筛选相关指标,将单因素有意义的指标纳入多因素回归进一步筛选,采用受试者特征(ROC)曲线评估诊断价值。结果 OP组CCL3及CCL5水平高于非OP组(P<0.05)。单因素logistic回归分析结果显示,病程(OR=1.004,P=0.005,95% CI:1.001~1.007),关节压痛指数(OR=1.030,P=0.042,95% CI:1.001~1.059),关节肿胀指数(OR=1.034,P=0.024,95% CI=1.004~1.065),CCL3(OR=1.010,P<0.001,95% CI:1.007~1.014)与CCL5(OR=1.007,P<0.001,95% CI:1.004~1.009)均为RA合并OP的危险因素。将单因素分析差异有统计学意义的变量纳入多因素logistic回归,结果显示,CCL3(OR=1.010,P<0.001,95% CI:1.007~1.014)与CCL5(OR=1.007,P<0.001,95% CI:1.004~1.009)为RA合并OP的独立危险因素。CCL3诊断RA合并OP的曲线下面积(AUC)为0.857(特异度为86.3%,灵敏度为73.0%),CCL5诊断RA合并OP的AUC为0.792(特异度为79.8%,灵敏度为66.0%);当联合该两项指标后诊断RA合并OP的AUC为0.905(特异度为77.2%,灵敏度为89.7%)(联合对比CCL3,Z=2.210,P=0.027)(联合对比CCL5,Z=3.210,P=0.001)。结论 CCL3及CCL5与RA合并OP具有明显相关性,且对其具有一定预测价值。
英文摘要:
      Objective To investigate the correlation between chemokine ligand 3 (CCL3) and chemokine ligand 5 (CCL5) with rheumatoid arthritis (RA) complicated by osteoporosis (OP). Methods A total of 200 RA patients treated at the Third Affiliated Hospital of Anhui Medical University (Hefei First People’s Hospital) from January 2022 to December 2025 were selected as the study subjects. They were divided into an OP group (114 cases) and a non-OP group (86 cases) based on whether their bone mineral density (BMD) was ≤ -2.5. Enzymelinked immunosorbent assay (ELISA) was employed to measure serum levels of CCL3 and CCL5. Univariate logistic regression was employed to preliminarily screen for relevant indicators. Variables found to be significant in the univariate analysis were included in the multivariate logistic regression for further screening. Receiver operating characteristic (ROC) curve was used to analyse the diagnostic value. Results In the comparison of general data, the levels of CCL3 and CCL5 in the OP group were higher than those in the non-OP group (P<0.05). Univariate logistic regression analysis results showed that disease duration (OR=1.004, P = 0.005, 95% CI: 1.001 - 1.007), tender joint count (OR=1.030, P = 0.042, 95% CI: 1.001 - 1.059), swollen joint count (OR=1.034, P = 0.024, 95% CI: 1.004 - 1.065), CCL3 (OR=1.010, P<0.001, 95% CI: 1.007 - 1.014), and CCL5 (OR=1.007, P<0.001, 95% CI: 1.004 - 1.009) were all risk factors for RA complicated with OP. Multivariate logistic regression analysis, incorporating variables significant in the univariate analysis, revealed that CCL3 (OR=1.010, P<0.001, 95% CI: 1.007 ~ 1.014) and CCL5 (OR=1.007, P<0.001, 95% CI: 1.004 ~ 1.009) were independent risk factors for RA complicated with OP. The area under the curve (AUC) for diagnosing RA with OP using CCL3 was 0.857, with a specificity of 86.3% and a sensitivity of 73.0%. The AUC for CCL5 was 0.792 (specificity 66.0%, sensitivity 79.8%). When these two indicators were combined, the AUC for diagnosing RA with OP was 0.905 (specificity 77.2%, sensitivity 89.7%) (combined model vs. CCL3: Z=2.21, P=0.027; combined model vs. CCL5: Z=3.21, P=0.001). Conclusion CCL3 and CCL5 are significantly correlated with RA complicated with OP and have certain predictive value for this condition.
查看全文   查看/发表评论  下载PDF阅读器
关闭